Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19-Reference-Cited by-同舟云学术

Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19

Published:2020-10-14 Issue:6 Volume:3 Page:1278-1292
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Bocci Giovanni¹,Bradfute Steven B.²,Ye Chunyan²,Garcia Matthew J.³,Parvathareddy Jyothi⁴,Reichard Walter⁴,Surendranathan Surekha⁴,Bansal Shruti⁴,Bologa Cristian G.¹,Perkins Douglas J.²,Jonsson Colleen B.⁴^ORCID,Sklar Larry A.³,Oprea Tudor I.¹⁵⁶^ORCID

Affiliation:

1. Translational Informatics Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, United States

2. Center for Global Health, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, United States

3. UNM Center for Molecular Discovery, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, United States

4. Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 3816, United States

5. Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, 413 90, Sweden

6. Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2200, Denmark

Funder

NIH Office of the Director

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00131

Reference77 articles.

1. Coronavirus outbreak officially declared a pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (accessed 2020).

2. COVID-19 World Map. https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/world-map.html.

3. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/.

4. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment.

5. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions;Journal of Medicinal Chemistry;2023-10-30

2. An Ensemble Approach for Prioritizing Antivirals Against COVID-19 via Heterogeneous Network Inference-Based Inductive Matrix Completion;Journal of Computational Biophysics and Chemistry;2023-10-19

3. Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CLPro) activity in silico and in vitro;Scientific Reports;2023-10-10

4. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant;Pharmaceutics;2023-07-05

5. A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine;2023-06-28